Skip to main content
    S

    Surgery Partners Inc (SGRY)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $26.79
    -0.16 (-0.59%)

    Market Cap: $3.53B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Surgery Partners Inc (SGRY) Financials: Revenue, Profit and Cash Flow

    Updated Nov 9, 2026. Financial statements from company filings, amounts in US dollars.

    Surgery Partners reported revenue of $3.31B for the fiscal year ended Dec 31, 2025, up 6.2% from the year before. That year, net income was $98.90M with a net margin of 3.0%, operating cash flow was $274.30M and free cash flow was $195.60M. The quarter ended Sep 30, 2026 had revenue of $815.30M and net income of $14.10M.

    Revenue and Margins

    The operating margin was 11.8% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $1.15B, a compound annual rate of 12.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$3.31B+6.2%70.7%11.8%3.0%
    Dec 2024$3.11B+13.5%38.3%11.2%0.4%
    Dec 2023$2.74B+8.0%37.5%12.0%4.9%
    Dec 2022$2.54B+14.1%42.7%13.6%3.4%
    Dec 2021$2.23B+19.6%42.4%13.6%3.2%
    Dec 2020$1.86B+1.6%41.5%9.8%0.1%
    Dec 2019$1.83B+3.4%42.2%12.9%2.5%
    Dec 2018$1.77B+32.1%28.0%4.4%-5.4%
    Dec 2017$1.34B+17.1%24.4%11.8%-4.0%
    Dec 2016$1.15BN/A28.3%17.2%7.4%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 691.2% from the year before. In the quarter ended Sep 2026, net income fell 44.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$3.31B$3.11B$2.74B$2.54B$2.23B$1.86B$1.83B$1.77B$1.34B$1.15B
    Cost of revenue$971.00M$1.92B$1.71B$1.46B$1.28B$1.09B$1.06B$1.27B$1.01B$821.20M
    Gross profit$2.34B$1.19B$1.03B$1.08B$944.40M$771.40M$773.50M$496.80M$327.42M$324.24M
    Operating income$389.50M$348.80M$328.00M$345.20M$302.20M$183.00M$235.90M$77.80M$158.23M$196.48M
    Net income$98.90M$12.50M$135.30M$87.00M$70.70M$1.30M$45.10M-$95.60M-$52.98M$85.08M
    EBITDA$565.50M$501.40M$446.10M$460.00M$401.00M$277.80M$310.00M$145.20M$251.88M$232.30M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$815.30M$848.90M$810.90M$885.00M$821.50M$826.20M$776.00M$864.40M$770.40M$762.10M$717.40M$735.40M
    Gross profit$308.00M$595.80M$563.50M$1.06B$369.80M$376.00M$278.00M$346.70M$292.40M$293.80M$259.30M-$152.30M
    Operating income$85.60M$102.10M$65.80M$110.20M$105.70M$111.70M$61.90M$127.10M$60.90M$84.80M$76.00M$101.40M
    Net income$14.10M$29.70M-$2.10M$29.00M$25.30M$44.90M-$300.00K-$46.60M$6.40M$28.40M$24.30M$46.70M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $3.70B exceeded cash and equivalents by $3.46B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$8.12B$7.89B$6.88B$6.68B$6.12B$5.41B$5.02B$4.68B$4.62B$2.30B
    Current assets$1.15B$1.12B$895.00M$921.00M$946.10M$801.50M$525.50M$588.30M$563.23M$361.95M
    Cash and equivalents$239.90M$269.50M$195.90M$282.90M$389.90M$317.90M$92.70M$184.30M$174.91M$69.70M
    Total liabilities$4.59B$4.25B$3.51B$3.40B$3.82B$3.79B$3.32B$2.89B$2.66B$1.80B
    Short-term debt$99.30M$101.40M$73.30M$62.80M$60.40M$64.40M$56.00M$55.60M$58.73M$27.82M
    Long-term debt$3.60B$3.27B$2.70B$2.56B$2.88B$2.79B$2.52B$2.27B$2.13B$1.41B
    Shareholder equity$1.71B$1.79B$1.99B$2.00B$1.09B$115.60M$296.80M$404.60M$654.73M$9.68M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$7.05B$8.05B$8.04B$8.24B$7.95B$7.95B$7.95B$7.89B$7.53B$7.49B$6.98B$6.88B
    Total liabilities$3.79B$4.58B$4.56B$4.72B$4.39B$4.38B$4.36B$4.25B$3.99B$3.87B$3.61B$3.51B
    Cash and equivalents$354.50M$216.70M$182.30M$239.90M$203.40M$250.10M$229.30M$269.50M$221.80M$213.50M$185.20M$195.90M
    Shareholder equity$1.66B$1.67B$1.69B$1.71B$1.73B$1.75B$1.74B$1.79B$1.90B$1.95B$1.97B$1.99B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 71.3% of operating cash flow. Dividends came to 115.2% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$274.30M$300.10M$293.80M$158.80M$87.10M$246.90M$129.50M$144.60M$120.94M$125.24M
    Capital expenditures$78.70M$90.40M$88.80M$80.60M$57.60M$42.90M$73.60M$39.80M$29.60M$39.11M
    Free cash flow$195.60M$209.70M$205.00M$78.20M$29.50M$204.00M$55.90M$104.80M$91.34M$86.13M
    Dividends paid$225.40M$160.90M$137.90M$150.20M$164.50M$137.00M$124.40M$119.00M$1.32M$85.87M
    Share repurchasesN/AN/AN/A$25.20M$27.60M$0$0$2.00MN/A$0
    Investing cash flow-$246.60M-$488.50M-$225.60M-$307.90M-$331.70M-$88.40M-$85.20M-$128.90M-$783.45M-$184.75M
    Financing cash flow-$57.30M$262.00M-$155.20M$42.10M$316.30M$66.70M-$135.90M-$6.30M$767.72M$71.28M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$103.50M$59.30M$11.70M$103.40M$83.60M$81.30M$6.00M$111.40M$65.20M$82.80M$40.70M$62.60M
    Capital expenditures$24.50M$21.80M$16.00M$12.80M$19.80M$23.40M$22.70M$22.30M$20.20M$26.90M$21.00M$19.80M
    Free cash flow$79.00M$37.50M-$4.30M$90.60M$63.80M$57.90M-$16.70M$89.10M$45.00M$55.90M$19.70M$42.80M
    Last 12 quarters

    Frequently Asked Questions About SGRY

    What is Surgery Partners' annual revenue?

    Surgery Partners reported revenue of $3.31B for the fiscal year ended Dec 31, 2025.

    How fast is Surgery Partners' revenue growing?

    Revenue was up 6.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 9.2%.

    Is Surgery Partners profitable?

    Yes. Surgery Partners reported net income of $98.90M for the fiscal year ended Dec 31, 2025, with a net margin of 3.0%.

    How much free cash flow does SGRY generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $274.30M minus capital expenditures of $78.70M produced free cash flow of $195.60M.

    How much debt does Surgery Partners have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $3.60B, short-term debt of $99.30M and cash and equivalents of $239.90M.